Metsera, Inc. (NASDAQ:MTSR – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as $32.33 and last traded at $32.19, with a volume of 70254 shares traded. The stock had previously closed at $30.58.
Metsera Trading Down 0.7 %
About Metsera
Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
See Also
- Five stocks we like better than Metsera
- How to Choose Top Rated Stocks
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 3 Tickers Leading a Meme Stock Revival
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is a Stock Market Index and How Do You Use Them?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Metsera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metsera and related companies with MarketBeat.com's FREE daily email newsletter.
